US FDA News: FDA approves new antibiotic to treat community-acquired bacterial pneumonia

The FDA approved Xenleta (lefamulin) to treat adults with community-acquired bacterial pneumonia.
Read more: FDA approves new antibiotic to treat community-acquired bacterial pneumonia